Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer Ruchika Sharma22 Jun 2024 11:11 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
Celecoxib could reduce risk of colon cancer recurrence for subset of patients, claims study Dr. Kamal Kant Kohli22 Jun 2024 7:45 AM ISTAn analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...
Glowing dye helps surgeons eradicate prostate cancer, claims research Dr. Kamal Kant Kohli20 Jun 2024 8:00 PM ISTA glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer...
Sunshine in a Pill: High-Dose Oral Vitamin D Targets Cancer Treatment Skin Toxicities, study reveals Medha Baranwal20 Jun 2024 8:00 AM ISTUSA: As cancer treatment advances, so do strategies to manage its side effects. A new frontier in supportive care has emerged with high-dose oral...
Androgen receptor signaling inhibitors associated with Increased cardiovascular risks ,warns study Jacinthlyn Sylvia19 Jun 2024 10:15 PM ISTCardiovascular (CV) events remain a significant cause of mortality among men with advanced and metastatic prostate cancer (PCa). A recent study...
How to improve Accessibility issues in cancer care: JAMA Dr. Kamal Kant Kohli19 Jun 2024 7:15 AM ISTResearchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their...
Advancements in MR Imaging: Study Explores Lower Gadolinium Doses for Meningioma Diagnosis Medha Baranwal18 Jun 2024 8:30 PM ISTCanada: In medical imaging, a cutting-edge study is reshaping the landscape of meningioma diagnosis by exploring lower gadolinium doses for magnetic...
Sir Ganga Ram Hospital Doctors use robotic surgery to remove complex tumor between woman's bladder, uterus Kajal Rajput18 Jun 2024 12:45 PM ISTNew Delhi: In a delicate surgical procedure, doctors at Sir Ganga Ram Hospital were able to remove a complex tumor located between a young woman's...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
Fertility-Sparing Surgery versus Standard Surgery: 5-Year Life Expectancy Disparity Revealed in new study Medha Baranwal18 Jun 2024 5:00 AM ISTUSA: In the realm of cervical cancer treatment, a pivotal debate has long simmered: Should patients opt for fertility-sparing surgery or adhere to the...
Sarcopenia obesity associated with reduced overall survival and quality of life among cancer patients:JAMA Jacinthlyn Sylvia17 Jun 2024 9:00 PM ISTA recent study published in the Journal of American Medical Association on sarcopenic obesity (SO) revealed a significant correlation with...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
